IBM and IDC Life Science Insights examined challenges and possible resolutions to these challenges that were debated at the first World Wide BioBank Summit held in Nice, France in March 2004.
BioBanks: Collaborating for Cures– IDC and IBM
IBM and IDC Life Science Insights examined six high priority challenges and possible resolutions to these challenges that were debated at the BioBank Summit II, Collaborating for Cures, held in Tarrytown, NY in November 2004. These challenges included: Scientific Quality Assurance, IT Infrastructure, Regulatory and Policy Challenges, Biobanking in Clinical Trials, Data Standards/Semantic Interoperability, and Funding.
International Journal for Banking, Engineering and Transplantation of Cells and Tissues
- Cell and Tissue Banking is an international, peer-reviewed journal that covers the complete spectrum of cell and tissue banking.
- Cell and Tissue Banking provides a forum for disseminating information to scientists and clinicians involved in the banking and transplantation of cells and tissues.
NIH National Biospecimen Network Blueprint
The NBN would create a comprehensive framework for sharing and comparing research results through a robust, flexible, scalable, and secure bioinformatics system that supports the collection, processing, storage, annotation, and distribution of biospecimens and data using standard operating procedures based on best practices.
Property Rights in Blood, Genes and Data
Who Owns Our DNA? Taking a case and context driven approach and backing up traditional legal analysis with historical analogies, web-surveys and practical experience, Jasper Bovenberg provides counter-intuitive, provocative and practical answers and recommendations for such controversial issues as how to share the benefits of DNA research, whether or not to recognize personal property rights in bodily material and access to biomedical datasets in academia.
RAND Report: Case Studies of Existing Human Tissue Repositories
RAND has conducted case studies of 12 existing human tissue repositories to evaluate their utility for genomics- and proteomics-based cancer research and to identify "best practices" necessary for establishing a national tissue resource and data bank to optimize and accelerate genomics- and proteomics-based research.
